• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯病的皮肤病变(胫前黏液性水肿)。150例病例回顾。

Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases.

作者信息

Fatourechi V, Pajouhi M, Fransway A F

机构信息

Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

出版信息

Medicine (Baltimore). 1994 Jan;73(1):1-7. doi: 10.1097/00005792-199401000-00001.

DOI:10.1097/00005792-199401000-00001
PMID:8309359
Abstract

Pretibial myxedema is an uncommon manifestation of Graves disease, and little information is available regarding its natural course and its relation to other manifestations of Graves disease. We reviewed 150 consecutive cases with the diagnosis of pretibial myxedema over a 20-year period in a referral center. Only 1 patient in this group did not have ophthalmopathy, whereas 88% had significant proptosis and 30% required orbital decompression surgery. Dermopathy was a late manifestation of Graves disease, and its onset usually followed the diagnosis of hyperthyroidism and ophthalmopathy. In a few patients, dermopathy preceded diagnosis of hyperthyroidism or onset of ophthalmopathy. Fourteen patients were never clinically hyperthyroid; spontaneous hypothyroidism had developed in 11 in this group. All cases involved the lower extremities, with only 1 patient having combined upper and lower extremity involvement. The most common form of thyroid dermopathy was nonpitting edema, followed by nodular and plaque forms, which occurred with equal frequency. The polypoid form occurred in 1 patient and the elephantiasic form in another; 7.3% had thyroid acropachy. Follow-up was available for 120 patients (range, 3 mo to 19 yr; mean, 3.2 yr), and complete remission was observed in only 12 patients. Topically applied corticosteroid therapy was used in 76 patients, and in this group 38% had sustained long-term partial remission, as opposed to 18% in the group receiving no corticosteroid therapy.

摘要

胫前黏液性水肿是格雷夫斯病的一种罕见表现,关于其自然病程及其与格雷夫斯病其他表现的关系,目前所知甚少。我们回顾了一家转诊中心在20年期间连续诊断为胫前黏液性水肿的150例病例。该组中只有1例患者没有眼病,而88%的患者有明显突眼,30%的患者需要进行眼眶减压手术。皮肤病变是格雷夫斯病的晚期表现,其发病通常在甲状腺功能亢进症和眼病诊断之后。在少数患者中,皮肤病变先于甲状腺功能亢进症的诊断或眼病的发作。14例患者临床上从未出现甲状腺功能亢进;该组中有11例出现了自发性甲状腺功能减退。所有病例均累及下肢,只有1例患者上下肢均受累。甲状腺皮肤病变最常见的形式是非凹陷性水肿,其次是结节状和斑块状,二者出现频率相同。息肉样形式出现在1例患者中,象皮肿样形式出现在另一例患者中;7.3%的患者有甲状腺性杵状指。120例患者获得了随访(范围为3个月至19年;平均为3.2年),仅12例患者完全缓解。76例患者使用了局部应用的皮质类固醇疗法,该组中有38%的患者长期持续部分缓解,而未接受皮质类固醇治疗的组中这一比例为18%。

相似文献

1
Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases.格雷夫斯病的皮肤病变(胫前黏液性水肿)。150例病例回顾。
Medicine (Baltimore). 1994 Jan;73(1):1-7. doi: 10.1097/00005792-199401000-00001.
2
Dermopathy of Graves' disease (pretibial myxedema): long-term outcome.格雷夫斯病的皮肤病变(胫前黏液性水肿):长期预后
J Clin Endocrinol Metab. 2002 Feb;87(2):438-46. doi: 10.1210/jcem.87.2.8220.
3
Pretibial myxedema: pathophysiology and treatment options.胫前黏液性水肿:病理生理学与治疗选择
Am J Clin Dermatol. 2005;6(5):295-309. doi: 10.2165/00128071-200506050-00003.
4
Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution.无眼病情况下的早发性胫前黏液性水肿:形态学演变
Cutis. 1996 Sep;58(3):211-4.
5
[A rare hyperthyroid syndrome].[一种罕见的甲状腺功能亢进综合征]
Minerva Endocrinol. 2004 Jun;29(2):71-5.
6
Thyroid dermopathy and acropachy in pediatric patients.小儿患者的甲状腺皮肤病和指端粗厚症
Pediatr Dermatol. 2018 Nov;35(6):e371-e374. doi: 10.1111/pde.13670. Epub 2018 Sep 6.
7
Elephantiasic thyroid dermopathy.象皮病样甲状腺皮肤病
Hong Kong Med J. 2006 Apr;12(2):159-60.
8
Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period.甲状腺性肢端病:26年间在一家机构治疗的40例患者的报告。
J Clin Endocrinol Metab. 2002 Dec;87(12):5435-41. doi: 10.1210/jc.2002-020746.
9
Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.格雷夫斯眼病合并胫前黏液性水肿的眼眶减压术
J Endocrinol Invest. 1993 Jun;16(6):433-7. doi: 10.1007/BF03348875.
10
Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis.对利妥昔单抗和血浆置换有反应的难治性象皮病性甲状腺皮肤病。
Australas J Dermatol. 2012 Feb;53(1):e1-4. doi: 10.1111/j.1440-0960.2010.00693.x. Epub 2010 Sep 10.

引用本文的文献

1
The evolving therapeutic landscape of Graves' disease in adults: present and future.成人Graves病不断演变的治疗格局:现状与未来。
Eur Thyroid J. 2025 Jul 22;14(4). doi: 10.1530/ETJ-25-0078. Print 2025 Aug 1.
2
Management Aspects of Medical Therapy in Graves Disease.格雷夫斯病的药物治疗管理方面
Endocr Pract. 2025 Apr;31(4):536-546. doi: 10.1016/j.eprac.2024.12.012. Epub 2024 Dec 17.
3
Graves disease: latest understanding of pathogenesis and treatment options.格雷夫斯病:发病机制和治疗选择的最新认识。
Nat Rev Endocrinol. 2024 Nov;20(11):647-660. doi: 10.1038/s41574-024-01016-5. Epub 2024 Jul 22.
4
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' disease.Graves-PCD 研究:随机、剂量探索、适应性临床试验方案,评估在严重 Graves 病中使用浆细胞耗竭剂达雷妥尤单抗的效果。
BMJ Open. 2024 Jun 12;14(6):e079158. doi: 10.1136/bmjopen-2023-079158.
5
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin.抗 CD20 单克隆抗体治疗皮肤自身免疫性疾病的综述。
Am J Clin Dermatol. 2023 Mar;24(2):247-273. doi: 10.1007/s40257-022-00751-7. Epub 2023 Jan 11.
6
Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves' Disease having Normally Appearing Pretibial Skin: A Case-Control Study.格雷夫斯病患者胫前皮肤外观正常情况下甲状腺皮肤病变的组织病理学证据及其与甲状腺相关眼病的相关性:一项病例对照研究
Indian J Endocrinol Metab. 2022 Mar-Apr;26(2):141-148. doi: 10.4103/ijem.ijem_504_21. Epub 2022 Jun 6.
7
Rituximab therapy for a severe case of pretibial myxedema.利妥昔单抗治疗严重胫前黏液性水肿一例
JAAD Case Rep. 2021 Feb 3;10:28-30. doi: 10.1016/j.jdcr.2021.01.033. eCollection 2021 Apr.
8
Pretibial myxedema in a euthyroid patient: a case report.一名甲状腺功能正常患者的胫前黏液性水肿:病例报告
Thyroid Res. 2021 Mar 1;14(1):4. doi: 10.1186/s13044-021-00096-z.
9
Pretibial Myxedema in a Euthyroid Patient.一名甲状腺功能正常患者的胫前黏液性水肿。
J Clin Aesthet Dermatol. 2021 Jan;14(1):21-23. Epub 2021 Jan 1.
10
Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema.促甲状腺激素受体自身免疫和多种危险因素中的局部因素主要参与胫前黏液性水肿的发生。
J Clin Med Res. 2020 Nov;12(11):711-723. doi: 10.14740/jocmr4352. Epub 2020 Nov 3.